| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Adena Health System offers a variety of Behavioral Health Services. Our mission is to assist each person in achieving the highest quality of life possible.
We are a rapidly growing team that is passionate about bringing the latest innovations in digital medicine to health systems, payers and practices.
Acumen is a Burlingame, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care. Aerie Pharmaceuticals discovers, develops, and commercializes first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye. See the future of eye care with Aerie.